JP Morgan Downgrades Emergent Biosolutions (EBS)
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
On March 17, 2023,
JP Morgan
downgraded
their outlook for Emergent Biosolutions (NYSE:EBS) from Neutral to Underweight.
JP Morgan
downgraded
their outlook for Emergent Biosolutions (NYSE:EBS) from Neutral to Underweight.
